Stocktoria
Jyong Biotech Ltd. MENS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-06-17
Jyong Biotech Ltd. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| R&D expense | $813,000 | $927,000 |
| Operating income | -$2.6M | -$2.1M |
| Net income | -$4.7M | -$3.0M |
| EPS (diluted) | $-0.06 | $-0.04 |
| Operating cash flow | -$3.0M | -$3.6M |
| Total assets | $20.8M | $6.4M |
| Total liabilities | $45.7M | $42.9M |
| Shareholders' equity | -$24.9M | -$36.5M |
Source: SEC EDGAR filings · CIK 0001954488 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.